
Burning Rock Biotech fell 13.0% from $15.28 to $13.29, behind the S&P 500's +13.3%. Its worst day was Mar 13 (−29.0%), and its low came Jun 17 at $7.04.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.20 was reported on $18.5M revenue.
−1.2% · S&P 500 −1.5%
Story events cover the past 12 months · Times ET
Burning Rock Biotech shares rose 24.4%, while the S&P 500 rose 0.7%.
+24.4% · S&P 500 +0.7%
Burning Rock Biotech shares rose 19.4%, while the S&P 500 fell 0.5%.
+19.4% · S&P 500 −0.5%
Burning Rock Biotech closed at its highest level of the year, 168.7% above where the year started.
+32.2%, the year's best day · S&P 500 +0.5%
EPS of $-0.20 was reported on $18.1M revenue.
−2.9% · S&P 500 −1.5%
EPS of $-0.20 was reported on $15.6M revenue.
−9.8% · S&P 500 −0.3%
Burning Rock Biotech closed at its lowest level of the year, 53.9% below where the year started.
−13.4% · S&P 500 −1.5%
Burning Rock Biotech shares rose 24.3%, while the S&P 500 fell 0.0%.
+24.3% · S&P 500 0.0%
EPS of $-0.20 was reported on $19.9M revenue.
−3.1% · S&P 500 −0.6%
Burning Rock Biotech shares rose 19.4%, while the S&P 500 fell 0.1%.
+19.4% · S&P 500 −0.1%
Where it ended: a close of $13.29 on Nov 13, 2026. Up next: Q3 2026 earnings on Nov 27, 2026.
Nothing in the past 12 months.
All BNR analyst actionsNothing in the past 12 months.
All BNR dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BNR and SPY from Benzinga historical bars. Not investment advice.